Dominick J Angiolillo, MD,PhD
University of Florida College of Medicine Jacksonville · University of Florida
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Dominick J Angiolillo, MD,PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:54 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07225842 · The Bridging Antiplatelet Therapy With Cangrelor 2 StudyUniversity of Florida · recruiting · Coronary Arterial Disease (CAD)
- Ph4NCT07025148 · Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2)University of Florida · recruiting · Coronary Arterial Disease (CAD), Percutaneous Coronary Intervention (PCI)
- Ph4NCT05681702 · Tailoring Bleeding Reduction Approaches in Patients Undergoing PCIUniversity of Florida · completed · Coronary Artery Disease · principal investigator
- Ph4NCT04483583 · Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After PCIUniversity of Florida · completed · Coronary Artery Disease
- Ph4NCT04484259 · Ticagrelor With and Without Aspirin in Patients With Diabetes MellitusUniversity of Florida · completed · Diabetes Mellitus, Type 2, Coronary Artery Disease · principal investigator
- Ph4NCT04006288 · Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery DiseaseUniversity of Florida · completed · Coronary Artery Disease
- Ph4NCT03718429 · Pharmacodynamic Effects of Low-dose Rivaroxaban With Antiplatelet TherapiesUniversity of Florida · completed · Coronary Artery Disease, Peripheral Arterial Disease, Atrial Fibrillation · principal investigator
- Ph4NCT03489863 · Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-function: a Validation StudyUniversity of Florida · completed · Coronary Artery Disease · principal investigator
- Ph4NCT03437044 · Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCIUniversity of Florida · completed · Diabetes Mellitus, Type 2, Coronary Artery Disease · principal investigator
- N/ANCT02724319 · Implementation of CYP2C19 Genotyping to Guide Antiplatelet TherapyUniversity of Florida · completed · Coronary Artery Disease
- Ph2NCT02714413 · Effect of D-allulose in Addition to Oral Sucrose LoadUniversity of Florida · completed · Blood Glucose
- Ph4NCT02567461 · Edoxaban in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and ClopidogrelUniversity of Florida · completed · Coronary Artery Disease
- Ph4NCT02548650 · Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes MellitusUniversity of Florida · completed · Myocardial Infarction, Diabetes Mellitus, Peripheral Arterial Disease
- Ph4NCT02545933 · Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and TicagrelorUniversity of Florida · completed · Myocardial Infarction
- Ph4NCT02539160 · Impact of Chronic Kidney Disease on the Effects of Ticagrelor in Patients With Diabetes and Coronary Artery DiseaseUniversity of Florida · completed · Coronary Artery Disease, Diabetes Mellitus
- Ph4NCT02065479 · A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients Undergoing PCI With CYP2C19 Loss-of-function:University of Florida · completed · Coronary Artery Disease
- N/ANCT01731041 · Impact of Ticagrelor Re-load on Pharmacodynamic ProfilesUniversity of Florida · completed · Coronary Artery Disease
- Ph4NCT01201785 · Aspirin Dosing in Diabetic PatientsUniversity of Florida · completed · Type 2 Diabetes Mellitus, Coronary Artery Disease
- Ph1NCT01170533 · PPI and Clopidogrel ResponseUniversity of Florida · completed · Drug Interaction
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- IGNITE EP2 - Admin SupplementU01HG007269 · NHGRI · UNIVERSITY OF FLORIDA · PI Larisa Humma Cavallari, JULIE A. JOHNSON · fiscal years 2013 to 2024Named on NCT02724319
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.